Portugal Uses Horizon Scanning To Speed Up Market Entry For Innovative Drugs

Portugal’s medicines regulator, Infarmed, wants to prioritize new medicines and speed up access to innovation with a new horizon scanning initiative.

Portugal
Portugal Uses Horizon Scanning To Speed Up Market Entry Of Important New Drugs

Infarmed, Portugal’s medicines regulator is mapping pharmaceutical innovations expected to hit the market over the next two years with a new horizon scanning initiative. The project will help authorities in Portugal prioritize new treatments and speed up market entry.

As part of the project, some 200 companies have been asked to submit details of the reimbursement applications that they expect to file over 2018 and 2019 for new active...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography

How Pharma Companies Can Mitigate The Impact Of US Tariffs On The Supply Chain

 
• By 

If US tariffs on pharmaceutical supply chain products come into force they could be disruptive for companies. Ewan Townsend, of the international law firm Arnold & Porter, explains how companies can mitigate issues through negotiating with suppliers and reallocating tariff responsibilities.

Japan Price Cuts For Epkinly and Lunsumio Following CEA

 
• By 

Japan is cutting more drug reimbursement prices following cost effectiveness analysis and is applying the methodology to a new group of products including Wegovy and Leqembi.